RegenoCELL Therapeutics, Inc. a leader in adult stem cell therapy, has announced the opening of another state of the art facility in Greece for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell therapy.

The company’s treatment for congestive heart failure is administered at the Metropolitan Hospital in Athens, which is part of the PERSEUS Heath Care Group. Greece is a convenient location for patients living in Europe and offers patients an additional location where the company’s autologous stem cell treatments are permitted.

RegenoCELL Therapeutics, Inc. is a stem cell therapy company using adult stem cells for autologous treatment of patients. The Company plans to obtain regulatory approval in the United States and the European Community to market its stem cell treatments.